INTRODUCTION {#sec1-1}
============

The genus *Lagochilus*, belonging to Labiatae family, comprises 35 species distributed mainly in central Asia such as Turkistan, Iran, Afghanistan, Russian, Mongolia and China, of which 14 species have been found to distribute wild in China.\[[@ref1][@ref2]\] Some plants in this genus, including *L. inebrians* and *L. lanatonodus*, are employed as infusion or tincture as antihemorrhagic for their hemostatic effects.\[[@ref3][@ref4][@ref5]\] Some plants were also applied for the treatment of allergic dermatosis.\[[@ref6][@ref7][@ref8]\] Previous phytochemical studies revealed the presence of diterpenoids, flavonoids, coumarins, iridoid glycosides and polysaccharides in this genus.\[[@ref6][@ref7][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24]\] Pharmacological results indicated that diterpenoids from this genus, including lagochiline and its derivatives, could have the ability of hemostatic.\[[@ref20][@ref25]\]

*L. ilicifolius*, a folk medicine used for the treatment of hemostatic, inflammation and ulcer, distributes in northwest regions in China.\[[@ref26]\] In our previous studies, we have described a lignan from this plant.\[[@ref27]\] In a continued search for bioactive constituents from this plant, one new lignan, *erythro*-1-\[(4-O-β-D- glucopyranosyl- 3- methoxyl)-phenyl\]- 2- \[(5'-methoxyl)-pinoresinol\]-propane-1,3-diol (1, [Figure 1](#F1){ref-type="fig"}), and two known lignans tortoside C (2, [Figure 1](#F1){ref-type="fig"}) and sisymbrifolin (3, [Figure 1](#F1){ref-type="fig"}), were isolated from the whole herbs of *L. ilicifolius*. In the present paper, the structure elucidation of the new lignan is reported.

![Structure of isolated compounds 1--3 and selected HMBCs of the new lignan (compound 1)](PM-11-191-g001){#F1}

MATERIALS AND METHODS {#sec1-2}
=====================

*General procedure and reagents* Optical rotations were measured on a KRÜSS P8000-T digital polarimeter. UV spectra were measured with a UV-1901 recording spectrophotometer (Beijing Puxi General Instrument Co., Ltd., Beijing, China). IR spectra were recorded on Nicolet™-380 spectrophotometer from Thermo Electron. NMR spectra were recorded on Brucker AV-500 (Switerland, Bruker) with TMS as internal reference. HR-ESI-MS were obtained on Brucker APEXIII 7.0 TESLA FTMS (Switerland, Bruker).

Column chromatography (CC): silica gel (200-300 mesh, Qingdao Haiyang Chemical Co., Ltd., Qingdao, China), Sephadex LH-20 (GE-Healthcare Bio-Sciences AB, Uppsala, Sweden), D101 macroporous resin (Sinopharm Chemical Reagent Co., Ltd., Shanghai, China), microporous resin (MCI) (75-150 μm, Mitsubishi Chemical Corporation, Tokyo, Japan) and octadecylsilyl (ODS) (40-60 μm, Sepax Technologies Inc., USA). All reagents were of analytical grade.

Plant materical {#sec2-1}
---------------

The whole herbs of *L. ilicifolius* were collected in Yinchuan, Ningxia, China, in July 2009. A voucher specimen (No. 2009001) was identified by Professor Xu Hong, and has been deposited in the herbarium of Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine.

Extraction and isolation {#sec2-2}
------------------------

The whole herbs of *L. ilicifolius* (13 kg) were ground and exhaustively extracted with 95% ethanol at 80°C (for 2 h, 3 times). The solvent was evaporated *in vacuo* to yield a dry residue (489.8 g). The residue was then suspended in water and extracted successively with petroleum ether, dichloromethane and *n*-butanol to give four extracts including petroleum ether extract (163.0 g), dichloromethane extract (22.8 g), *n*-butanol extract (73.0 g) and H~2~O extract (231.0 g).

The *n*-butanol extract (73.0 g) was subjected to D101 column chromatography and eluted with H~2~O, 30% EtOH, 60% EtOH and 90% EtOH to give four fractions including Fr. H~2~O (54.0 g), Fr. 30% EtOH (12.0 g), Fr. 60% EtOH (5.0 g) and Fr. 90% EtOH (2.0 g).

Fr. 30% EtOH (12.0 g) was subjected to silica gel column chromatography and eluted by CH~2~Cl~2~-MeOH = 20:1 to yield Subfr. 1-2. Subfr. 1 was subsequently subjected to MCI and silica gel column chromatography (EtOAc-MeOH-H~2~O = 20:2:1) to afford compound tortoside C (2).

Fr. 60% (5.0 g) was subjected to MCI column chromatography to yield Subfr. 1-6. Subfr. 3 was subjected to Sephadex LH-20 column chromatography (eluted with MeOH) to afford compound sisymbrifolin (3). Subfr. 5 was subjected to silica gel (EtOAc- MeOH-H~2~O = 12:1:0.5) and ODS column chromatography (eluted with 40% MeOH), and further purified by Sephadex LH- 20 column chromatography (eluted with MeOH) to give compound *erythro* - 1- \[(4 -O-β-D- glucopyranosyl-3-methoxyl)-phenyl\]-2-\[(5'-methoxyl)-pinoresinol\]- propane-1,3-diol (1).

Cytotoxicity assay {#sec2-3}
------------------

PC12 cell line, derived from a rat pheochromocytoma, was obtained from the American Type Culture Collection (ATCC, Manassas, VA). The cells were maintained in Dulbecco\'s modified Eagles medium (DMEM) supplemented with 6% fetal bovine serum, 6% horse serum, 100 U/mL penicillin, and 100 mg/mL streptomycin at 37°C in a water-saturated 7.5% CO~2~ incubator. Cultured PC12 cells in 96-well-plate (15,000 cells/well) were pre-treated with various concentrations (0.1, 0.3, 1, 3, 10, 30, 100 μM) for 48 h. Cell viability test was performed with the addition of thiazolyl blue tetrazolium bromide (MTT) (Sigma, USA) in PBS at a final concentration of 0.5 mg/mL for 1 h. After the solution was removed, the purple precipitate inside the cells was re-suspended in DMSO and then measured at 570 nm absorbance.

RESULTS {#sec1-3}
=======

*Compound 1* white amorphous solid (CH~3~OH), \[α\]--16.7(c, 0.191, CH~3~OH). UV (CH~3~OH) λ~max~: 291 nm. IR (KBr) ν cm^-1^: 3 417, 2 930, 1 594, 1 514, 1 463, 1 422, 1 267, 1 224, 1 125, 1 075, 635. HR-ESI-MS: *m/z* 745.2711 \[M--H\]^--^ (calcd. 746.2786). ^1^H NMR and ^13^C NMR data were shown in [Table 1](#T1){ref-type="table"}.

###### 

NMR chemical shifts of compound 1 (125 MHz for ^13^C and 500 MHz for ^1^H)

![](PM-11-191-g002)

*Compound 2* white amorphous solid (CH~3~OH). EI-MS: *m/z* 553 \[M--H\]^--^. ^1^H NMR (Pyr, 500 MHz) δ~H~:7.05 (2H, d, *J* = 13.5Hz, H-2', 6'), 5.06 (2H, *J* = 4.5Hz, H-2, 6), 4.13 (2H, dd, *J* = 9.0, 4.5Hz, H-4a, 8a), 4.02 (2H, dd, *J* = 4.5, 4.5Hz, H-4e, 8e), 3.88 (6H, s, 2 × OCH~3~), 3.23-3.34 (H of sugar). ^13^C NMR (Pyr, 125MHz) δ~C~: 138.50 (C-5', 5"), 135.4 (C-4', 4"), 105.1 (C-glc-1), 105.0 (C-6', 6"), 86.4 (C-2, 6), 78.8 (C-glc-5), 78.5 (C-glc-3), 76.2 (C-4, 8), 72.4 (C-glc-2), 71.7 (C-glc-4), 62.7 (C-glc-6), 56.8 (OCH~3~), 54.9 (C-1, 5). The ^1^H and ^13^C NMR data are in accordance with those in literature,\[[@ref28]\] so compound 2 was identified as tortoside C.

*Compound 3* white powder (CH~3~OH). EI-MS: *m/z* 393 \[M--H\]^--^. ^1^H NMR (CD~3~OD, 500 MHz) δ~H~: 6.85 (1H, d = 2.5 Hz, H-2), 6.85 (1H, s, H-2'), 6.84 (1H, s, H-6'), 6.81 (1H, dd, *J* = 8.5, 2.0 Hz, H-6), 6.67 (1H, d, H = 8.5 Hz, H-5), 5.44 (1H, d, *J* = 6.0 Hz, H-7), 4.48 (1H, d, *J* = 4.0 Hz, H-7'), 3.77 (3H, s, 3-OCH~3~), 3.71 (3H, s, 3'-OCH~3~), 3.75 (2H, m, H-9), 3.59 (1H, m, H-8'), 3.45 (1H, d, *J* = 11.0 Hz, H-9a'), 3.40 (1H, d, *J* = 6.0Hz, H-8), 3.32 (1H, d, *J* = 11.5Hz, H-9b'). ^13^C NMR (CD~3~OD, 125MHz) δ~C~: 136.9 (C-1), 110.5 (C-2), 147.5 (C-4), 116.1 (C-5), 119.6 (C-6), 89.1 (C-7), 55.3 (C-8), 64.8 (C-9), 129.7 (C-1'), 112.5 (C-2'), 145.2 (C-3'), 149.1 (C-4'), 134.6 (C-5'), 116.6 (C-6'), 75.3 (C-7'), 77.6 (C-8'), 64.2 (C-9'). The ^1^H and ^13^C NMR data are in accordance with those in literature,\[[@ref29]\] so compound 3 was identified as sisymbrifolin.

DISCUSSION {#sec1-4}
==========

Compound 1 was a white amorphous solid, \[α\]--16.7(c 0.191, CH~3~OH). The molecular formula was deduced as C~37~H~46~O~16~ from negative HRESI-MS \[M--H\]^--^ at *m/z* 745.2711. The UV spectrum displayed a maximum absorption at 291 nm (CH~3~OH). The IR spectrum showed the presence of hydroxyl at 3417 cm^-1^, aromatic rings at 1594 and 1514 cm^-1^ and C--O--C bond at 1224 and 1075 cm^-1^.

The NMR data \[[Table 1](#T1){ref-type="table"}\] showed that 1 contained two ABX spin systems assignable to two 1,3,4-trisubstituted benzene rings at δ~H~ 6.81 (1H, *d*, *J* = 8.5 Hz, H-5), 6.77 (1H, *dd*, *J* = 8.5, 1.5 Hz, H-6), and 6.94 (1H, *d*, *J* = 1.5 Hz, H-2); and 7.08 (1H, *d*, *J* = 8.5 Hz, H-5"), 6.88 (1H, *d*, *J* = 8.5, 1.5 Hz, H-6") and 7.04 (1H, *d*, *J* = 1.5 Hz, H-2"); two magnetic equivalent aromatic protons at δ~H~ 6.65 (2H, s) were indicative of one symmetrical 1,3,4, 5-tetrasubstituted benzene ring. The ^1^H-NMR chemical shifts observed for the three benzene systems together with the presence of four aromatic methoxyl group signals at δ~H~ 3.85 (9H, s, 3'-OMe, 5'-OMe and 3-OMe) and 3.84 (3H, s, 3"-OMe) suggested the presence of two guaiacyl (3-methoxy-4-hydroxyphenyl) groups and one 3,5-dimethoxy-4-hydroxyphenyl in this compound.\[[@ref30]\] In addition, the NMR spectral data of 1 also established one unit of β-glucose, a *bis*-tetrahydrofuran ring\[[@ref31]\] and a propan-1,2,3-triol moiety.\[[@ref32]\] Detailed analysis of the above data of 1 suggested that compound 1 was a sesquilignan monoglucoside consisting of (+)-medioresinol,\[[@ref33]\] 3-(4-hydroxy-3-methoxyphenyl)-propan-1,2,3-triol and β-D-glucopyranose.

The NOESY correlation of the H-8" signal δ~H~ 4.25 (1H, brs) with the H-5 signal δ~H~ 6.81 (1H, d, *J* = 8.5 Hz) of the guaiacyl group in (+)-medioresinol indicated that 3-(4-hydroxy-3-methoxyphenyl)-propan-1,2,3-triol was connected to the C-4 position of (+)-medioresinol. The relatively small coupling constant of H-7" signal δ~H~ 4.90 (1H, *d*, *J* = 5.5 Hz) indicated that the glycerol moiety was in the *erythro*-configuration.\[[@ref34]\] The attached position of β-D-glucopyranose was determined by the HMBC correlation of the anomeric proton at δ~H~ 4.86 (1H, d, *J* = 7.5 Hz) with the signal at δ~C~ 147.5 (C-4"). The NMR spectral data of 1 was similar to that of a known sesquilignan monoglucoside *erythro*- 1- (4-*O*-β-D-glucopyranosyl-3,5-dimethoxy-phenyl)-2-syringaresinoxyl- propane-l, 3-diol.\[[@ref31]\] The only difference was that two methoxyl groups at δ~H~ 3.88 (5-OMe) and δ~H~ 3.84 (5"-OMe) present in the known sesquilignan monoglucoside had disappeared in 1; instead, two aromatic proton signals were observed at δ~H~ 6.81 (1H, d, *J* = 8.5, H-5) and δ~H~ 7.08 (1H, d, *J* = 8.5, H-5"). Based on similar chemical shifts and coupling constants of H-7 (δ 4.72, 1H, d, *J* = 4.5 Hz) and H-8 (δ 3.12, 1H, brs), H-7′ (δ 4.70, 1H, d, *J* = 4.5 Hz) and H-8′ (δ 3.12, 1H, brs) to those of *erythro*-1-(4-*O*-β-D-glucopyranosyl-3,5-dimethoxy- phenyl)-2-syringaresinoxyl-propane-l, 3-diol, the relative configuration of C-7, C-8, C-7′ and C-8′ of 1 was proposed to be the same as those of *erythro*-1-(4-*O*-β-D-glucopyranosyl-3,5-dimethoxy-phenyl)-2- syringaresinoxyl-propane-l, 3-diol with H-7, H-8, H-7′, H-8′ as *b*, *a*, *b* and *a*, respectively.\[[@ref31]\] Therefore, compound 1 was identified as *erythro*-1-\[(4-*O*-β-D-glucopyranosyl-3-methoxyl) phenyl\]-2-\[(5'-methoxyl)-pinoresinol\]-propane-1,3-diol. \[[Figure 1](#F1){ref-type="fig"}\].

Compound 1-3 were evaluated *in vitro* for cytotoxicity against PC12 cell line derived from a transplantable rat pheochromocytoma employing a MTT-assay. The new lignan (1) exhibited significant cytotoxicity with the IC~50~ value of 1.22 ± 0.03 mol/L.
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